Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 35.30
-1.25 (-3.42%)
Sep 16, 2025, 1:30 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 18.30 billion as of September 15, 2025. Its market cap has increased by 14.02% in one year.
Market Cap
18.30B
Enterprise Value
19.06B
Revenue
6.00B
Ranking
n/a
PE Ratio
24.06
Stock Price
35.30
Market Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 18.30B, an increase of 3,036.51%. That is a compound annual growth rate of 19.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 18.30B | 26.22% |
| Dec 31, 2024 | 14.50B | -1.41% |
| Dec 29, 2023 | 14.71B | -8.20% |
| Dec 30, 2022 | 16.02B | 128.36% |
| Dec 30, 2021 | 7.02B | 2.96% |
| Dec 31, 2020 | 6.81B | 20.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 321.06B |
| PharmaEssentia | 186.40B |
| Bora Pharmaceuticals Co., LTD. | 87.62B |
| Lotus Pharmaceutical | 49.18B |
| Lumosa Therapeutics | 48.10B |
| Oneness Biotech | 34.10B |
| Polaris Group | 29.12B |
| Center Laboratories | 27.28B |